Generic Aricept Approved for Alzheimer’s Dementia - Health News - Health.com
Links shared publicly online about this topic.
- 1,524total visits
Generic Aricept Approved for Alzheimer’s Dementia - Health News - Health.com
View full resource at news.health.com
Tags: Dementia, Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Drug, FDA, Aricept
Most Recently Shared on December 17, 2009 at 3:23 pm By:
Generic Aricept Approved for Alzheimer’s Dementia: Generic versions of the drug Aricept (donepezil hydrochloride)... http://bit.ly/7zCye7
2 medical experts criticize FDA approval of high-dose Aricept - Related Stories - Hospice and Palliative Medicine SmartBrief
smartbrief.com — “The FDA's authorization of a higher dose of Aricept, an Alzheimer's disease drug marketed by Eisai and Pfizer, went against reviewers' advice and regulatory standard, Steven Woloshin and Lisa Schwartz of Dartmouth College wrote in BMJ. They said 23-milligram Aricept did not significantly improve co…” View full resource at smartbrief.com
Most Recently Shared on March 28, 2012 at 9:06 pm By:
Lionel Lim Physician, Doctor, Internist, and Geriatrician
2 medical experts criticize FDA approval of high-dose Aricept http://t.co/2ThotsPL
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 27, 2012 at 2:04 am By:
Brad Stuart Internist, Pain Medicine Physician, Physician, and Doctor
A new low in drug marketing + lack of regulation http://t.co/9HF6cWJR
Higher dose of Alzheimer's drug approved despite FDA warnings, report shows - McKnight's Long Term Care News
mcknights.com — “Makers of the Alzheimer's drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.” View full resource at mcknights.com
Most Recently Shared on March 26, 2012 at 11:03 am By:
Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.
" /> Alzheimer's Reading Room Health Advocate
Higher dose of Alzheimer's drug approved despite FDA warnings, report shows http://t.co/wZ7IlICq #alzheimer's #news
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 24, 2012 at 8:30 pm By:
Should this #Alzheimer drug's patent have been extended despite warning about troubling side effects? http://t.co/uGGdCFg2
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 24, 2012 at 3:58 am By:
Drug Dosage Was Approved Despite Warning: http://t.co/gLW3RU6E
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 11:06 pm By:
Amy Berman Health Organization
Deeply disturbing piece from NYTimes: Drug Dosage Was Approved Despite Warning http://t.co/msEYrQdM
Alzheimer’s drug sharply criticized - Spokesman.com - March 23, 2012
spokesman.com — “WASHINGTON – Watching Alzheimer’s disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food and Drug Administration will do little to help most patients and bring misery to some, say two medical investigators. The drug, Aricept 23 mg, is no more effective on the whole than the disappointing ones already on the market – but is more likely to cause gastr” View full resource at spokesman.com
Most Recently Shared on March 23, 2012 at 4:32 pm By:
Alzheimer’s drug sharply criticized - Fri, 23 Mar 2012 PST: WASHINGTON – Watching Alzheimer’s disease steal away... http://t.co/4h4I2bko
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 3:32 pm By:
George Huba, Ph.D. Psychologist, PhD, and Doctor
NYT: Drug Dosage Was Approved Despite Warning - Aricept 23 was developed by the Japanese pharmaceutical company Eisa... http://t.co/KAZJYoT9
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:57 pm By:
NYT: Drug Dosage Was Approved Despite Warning http://t.co/inId49mN
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:57 pm By:
NYT: Drug Dosage Was Approved Despite Warning http://t.co/inId49mN
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:05 pm By:
Susan Krauss Whitbourne Doctor, Psychologist, and PhD
Chilling tale about Aricept's approval for stronger dose despite high risks and lack of effectiveness. #pharma #psych http://t.co/wUEvIdMi
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 1:01 pm By:
Dr. Steven Z. Kussin Gastroenterologist, Physician, Doctor, and Internist
Two articles on your friendly BigPhama companies and Device companies. You are spending too much time worrying... http://t.co/AqRbDd1B
Experts challenge FDA over approval for new dose of Alzheimer's drug | Science Codex
sciencecodex.com — “Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts on bmj.com today. In the first of a new occasional” View full resource at sciencecodex.com
Most Recently Shared on March 23, 2012 at 11:58 am By:
Sara Stein MD Physician, Doctor, and Psychiatrist
#Dementia Pharma at its worst again, distorted advertising on Aricept to get you buying the new name brand version... http://t.co/puM4CgEj
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 11:49 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
Drug Dosage Was Approved Despite Warning: http://t.co/3Yuby2Wo
Drug Dosage Was Approved Despite Warning - NYTimes.com
nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.” View full resource at nytimes.com
Most Recently Shared on March 23, 2012 at 11:05 am By:
Drug Dosage Was Approved Despite Warning http://t.co/Mk0uqRGH
Advertisement
